- Patient/Guest
- Phlebotomist
- Updates
| A G Ratio Test | - |
|---|
|
Measure albumin to globulin ratio |
||
| Synonym | See updates | |
| Test Code | CDBIOPR0003 | |
| Test Type | Biochemistry | |
| Pre-Test Condition | See updates | |
| Report Availability | 1 D(s) | |
| # Test(s) | 1 | |
| Test details | Sample Report |
|---|---|
| A G Ratio Test |
|
| Synonym | See updates | ||
| Test Code | CDBIOPR0003 | ||
| Test Category | Liver disorders | ||
| Pre-Test Condition | See updates | ||
| |
Medical History | See updates | |
| Report Availability | 1 D(s) | ||
| Specimen/Sample | Serum; 2 mL; SST | ||
| Stability @21-26 deg. C | 6 Hr(s) | ||
| Stability @ 2-8 deg. C | 7 D(s) | ||
| Stability @ Frozen | 1 M(s) | ||
| # Test(s) | 1 | ||
| Processing Method | Spectrophotometry | ||
| **Albumin Globulin Ratio A G Ratio****FDA Status**: Standard laboratory procedure under CLIA; no specific FDA approval required.**Other Names**: A/G Ratio Test, Protein Profile.**Historical Breakthrough**: Developed in the 1950s to assess liver function, advancing hepatology.**Key Purpose and Impact**: Measures albumin-to-globulin ratio to diagnose liver, kidney, or immune disorders.**Preparation and Patient History**: Blood; report jaundice, edema, or chronic disease.**Consent Requirement**: Standard consent for diagnostic testing.**Clinical Value**: Sensitivity ~85%; specificity ~90%; detects abnormalities in ~60% of cases; guides diagnosis.**References Cited**: Testing.com Liver Tests 2023; Labcorp A/G Ratio Test 2025; UpToDate Liver Function Tests 2025 |
